Other cure related studies at CROI 2019
30 April 2019. Related: Conference reports, Cure-related research.
2019
Dual long-acting cabotegravir/rilpivirine injection submitted to FDA
30 April 2019. Related: Antiretrovirals.
Dolutegravir/3TC dual FDC (Dovato) approved in the US and given positive opinion in the EU
30 April 2019. Related: Antiretrovirals.
King’s launches transgender sexual health service with cliniQ
30 April 2019. Related: Other news.
30 April 2019 vol 20 no 5
30 April 2019. Related: PDFs.
29 March 2019: vol 20 no 4 – second CROI reports
28 March 2019. Related: Editorial.
Conference on Retroviruses and Opportunistic Infections (CROI 2019): second reports
28 March 2019. Related: Conference reports.
Maturation inhibitor GSK’232 reduces viral load by –1.5 log at day 10
28 March 2019. Related: Conference reports, Antiretrovirals.
Capsid inhibitor GS-6207 shows potential for 3-monthly injections
28 March 2019. Related: Conference reports, Antiretrovirals.
First phase 1 results from bNAb PGT121 in HIV positive people
28 March 2019. Related: Conference reports, Antiretrovirals.
Dolutegravir/3TC dual ART is as effective at lowest viral load cut-off as triple therapy in GEMINI studies
28 March 2019. Related: Conference reports, Antiretrovirals, Treatment strategies.
Same-day ART is effective in San Francisco Rapid-ART clinic
28 March 2019. Related: Conference reports, Antiretrovirals, Treatment strategies.
Integrase inhibitors and neural tube defects: more data still needed
28 March 2019. Related: Conference reports, Pregnancy.
Double-dose levonorgestrel implant does not overcome interaction with efavirenz
28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.
Efavirenz and rifampicin together reduce levels of injectable contraception
28 March 2019. Related: Conference reports, Women's health, PK and drug interactions.
Bedaquiline and delamanid safe when given together to treat drug resistant TB
28 March 2019. Related: Conference reports, TB coinfection.
Isoniazid preventative therapy in HIV positive pregnant women not linked to poor outcomes
28 March 2019. Related: Conference reports, TB coinfection.
Dear Doctor letter: Increased risk of treatment failure and increased risk of mother-to-child transmission of HIV infection dues to lower exposure of elvitegravir and cobicistat during the second and third trimesters of pregnancy
28 March 2019. Related: Pregnancy.
29 March 2019 vol 20 no 4
28 March 2019. Related: PDFs.
13 March 2019: vol 20 no 3 – first CROI reports
12 March 2019. Related: Editorial.
Conference on Retroviruses and Opportunistic Infections (CROI 2019): early reports
12 March 2019. Related: Conference reports.
UK patient likely to be the second person cured of HIV: two further cases at CROI 2019 of HIV remission after allogenic stem cell transplants
12 March 2019. Related: Conference reports, Cure-related research.
Phase 3 results with dual therapy cabotegravir/rilpivirine long-acting injections: ATLAS and FLAIR studies
12 March 2019. Related: Conference reports, Antiretrovirals.
Viral reservoir can explain persistent low level viraemia with good adherence on ART
12 March 2019. Related: Conference reports, Treatment strategies.
Dolutegravir suppresses viral load faster than efavirenz in late pregnancy: results from DolPHIN-2
12 March 2019. Related: Conference reports, Pregnancy.
Raltegravir achieves swifter viral load suppression in pregnancy than efavirenz
12 March 2019. Related: Conference reports, Pregnancy.
New option for PrEP – TAF/FTC is non-inferior to TDF/FTC: results of phase 3 DISCOVER study
12 March 2019. Related: Conference reports, HIV prevention and transmission.
Dolutegravir can be given with 3HP to prevent TB without dose adjustment
12 March 2019. Related: Conference reports, PK and drug interactions, TB coinfection.
Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity
12 March 2019. Related: Conference reports, PK and drug interactions, TB coinfection.
Shared housing compared to living alone: higher CD4, lower viral load and reduced inflammation in macaques
12 March 2019. Related: Conference reports, Coinfections and complications.
Selected webcasts at CROI 2019
12 March 2019. Related: Conference reports, PK and drug interactions.
i-Base Fit for Purpose report launched at CROI 2019
12 March 2019. Related: Supplements, Conference reports.
Pre-CROI Community HIV Cure Workshop 2019
12 March 2019. Related: Conference reports, Cure-related research.
US requires informed consent forms for clinical studies to be posted online
12 March 2019. Related: Research studies, Other news.
Reports from cure strategies meetings
12 March 2019. Related: On the web.
13 March 2019 vol 20 no 3
12 March 2019. Related: PDFs.
22 February 2019: vol 20 no 2 – remembering Mags…
20 February 2019. Related: Editorial.
27th International Workshop on HIV Drug Resistance and Treatment Strategies
20 February 2019. Related: Conference reports, Drug resistance.
Drug resistance in low- and middle-income countries
20 February 2019. Related: Conference reports, Drug resistance.
Remembering Dr Mags Portman: pioneer activist for sexual health
20 February 2019. Related: In memory.
BHIVA guidelines for adult TB/HIV coinfection (2018)
20 February 2019. Related: Guidelines, TB coinfection.
UK BHIVA pregnancy guidelines updated (2018)
20 February 2019. Related: Guidelines.
Regular marijuana smoking linked to lung disease in HIV positive but not HIV negative men
20 February 2019. Related: Coinfections and complications.
Civil society organisations push for a target of $18 billion for the Global Fund’s sixth replenishment
20 February 2019. Related: Treatment access.
Arabic translation of U=U factsheet
20 February 2019. Related: HIV prevention and transmission.
Recent papers from the Swiss HIV Cohort Study newsletter
20 February 2019. Related: On the web.
Fit for the Future: NHS long-term plan explained
20 February 2019. Related: On the web.
22 February 2019 vol 20 no 2
20 February 2019. Related: PDFs.
21 January 2019: vol 20 no 1: Brexit and other complications…
21 January 2019. Related: Editorial.
BMJ survey reports lack of NHS planning for Brexit: impact on drug supplies unknown
21 January 2019. Related: Treatment access.
BASHH, BHIVA, HIVPA and NHIVNA statement on a no-deal Brexit
21 January 2019. Related: Treatment access.
UK-CAB statement on Brexit, HIV and access to medicines
21 January 2019. Related: Treatment access.
Model predicts benefit of dolutegravir for all in sub-Saharan Africa outweighs risk
21 January 2019. Related: Treatment access.
Are integrase inhibitors linked to weight gain? – an evidence review
21 January 2019. Related: Side effects.
HIV is associated with higher biological age compared to chronological age
21 January 2019. Related: Ageing and life expectancy.
Frailty in older HIV positive people: independent associations with serious morbidity and mortality
21 January 2019. Related: Side effects, Coinfections and complications, Ageing and life expectancy.
US adult HIV guidelines updated (Oct 2018)
21 January 2019. Related: Guidelines.
NHS England doubles places on IMPACT PrEP study to 26,000
21 January 2019. Related: HIV prevention and transmission.
US CDC updates HIV rates in transgender people
21 January 2019. Related: HIV prevention and transmission.
UK annual HIV surveillance data published – full reports
21 January 2019. Related: HIV prevention and transmission.
Michigan State updates HIV disclosure laws to reflect impact of effective ART
21 January 2019. Related: HIV prevention and transmission, Other news.
Conference abstracts online
21 January 2019. Related: On the web.
Chemsex: online resources
21 January 2019. Related: On the web.
TAGline: Intellectual Property and Access
21 January 2019. Related: On the web.
Activists announce alternative 2020 conference in Mexico City
21 January 2019. Related: Other news.